Miyashita K - Search Results

1

Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents.

Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A, Kawakami K, Minamoto T. Shakoori A, et al. Among authors: miyashita k. Cancer Sci. 2007 Sep;98(9):1388-93. doi: 10.1111/j.1349-7006.2007.00545.x. Epub 2007 Jul 19. Cancer Sci. 2007. PMID: 17640304 Free PMC article.

2

Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma.

Miyashita K, Kawakami K, Nakada M, Mai W, Shakoori A, Fujisawa H, Hayashi Y, Hamada J, Minamoto T. Miyashita K, et al. Clin Cancer Res. 2009 Feb 1;15(3):887-97. doi: 10.1158/1078-0432.CCR-08-0760. Clin Cancer Res. 2009. PMID: 19188159

3

Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase.

Mai W, Kawakami K, Shakoori A, Kyo S, Miyashita K, Yokoi K, Jin M, Shimasaki T, Motoo Y, Minamoto T. Mai W, et al. Among authors: miyashita k. Clin Cancer Res. 2009 Nov 15;15(22):6810-9. doi: 10.1158/1078-0432.CCR-09-0973. Epub 2009 Nov 10. Clin Cancer Res. 2009. PMID: 19903789

4

An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta.

Miyashita K, Nakada M, Shakoori A, Ishigaki Y, Shimasaki T, Motoo Y, Kawakami K, Minamoto T. Miyashita K, et al. Anticancer Agents Med Chem. 2009 Dec;9(10):1114-22. doi: 10.2174/187152009789734982. Anticancer Agents Med Chem. 2009. PMID: 19925395 Review.

5

Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy.

Domoto T, Pyko IV, Furuta T, Miyashita K, Uehara M, Shimasaki T, Nakada M, Minamoto T. Domoto T, et al. Among authors: miyashita k. Cancer Sci. 2016 Oct;107(10):1363-1372. doi: 10.1111/cas.13028. Epub 2016 Sep 24. Cancer Sci. 2016. PMID: 27486911 Free PMC article. Review.

6

Detection of active fraction of glycogen synthase kinase 3beta in cancer cells by nonradioisotopic in vitro kinase assay.

Mai W, Miyashita K, Shakoori A, Zhang B, Yu ZW, Takahashi Y, Motoo Y, Kawakami K, Minamoto T. Mai W, et al. Among authors: miyashita k. Oncology. 2006;71(3-4):297-305. doi: 10.1159/000106429. Epub 2007 Jul 23. Oncology. 2006. PMID: 17652946

7

Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.

Furuta T, Sabit H, Dong Y, Miyashita K, Kinoshita M, Uchiyama N, Hayashi Y, Hayashi Y, Minamoto T, Nakada M. Furuta T, et al. Among authors: miyashita k. Oncotarget. 2017 Apr 4;8(14):22811-22824. doi: 10.18632/oncotarget.15206. Oncotarget. 2017. PMID: 28423558 Free PMC article. Clinical Trial.

8

Recurrent intracranial solitary fibrous tumor with cerebrospinal fluid dissemination. Case report.

Miyashita K, Hayashi Y, Fujisawa H, Hasegawa M, Yamashita J. Miyashita K, et al. J Neurosurg. 2004 Dec;101(6):1045-8. doi: 10.3171/jns.2004.101.6.1045. J Neurosurg. 2004. PMID: 15597767

9

Ossified peripheral middle cerebral artery aneurysm in a 30-year-old man.

Hayashi Y, Shima H, Kinoshita M, Nakada M, Miyashita K, Hamada J. Hayashi Y, et al. Among authors: miyashita k. J Clin Neurosci. 2009 Aug;16(8):1075-7. doi: 10.1016/j.jocn.2008.07.084. Epub 2009 May 8. J Clin Neurosci. 2009. PMID: 19427787 Free article.

10

Reversible acute bilateral blindness resulting from a frontal brain tumor: a case report.

Hayashi K, Nakada M, Miyashita K, Hayashi Y, Hamada J. Hayashi K, et al. Among authors: miyashita k. Br J Neurosurg. 2014 Dec;28(6):793-5. doi: 10.3109/02688697.2014.913774. Epub 2014 May 5. Br J Neurosurg. 2014. PMID: 24799276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,020 results

Search Page

Filters